Related Experiment Videos
Disease patterns and tissue cytokine profiles in giant cell arteritis
C M Weyand1, N Tetzlaff, J Björnsson
1Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Arthritis and Rheumatism
|January 1, 1997
Summary
Giant cell arteritis (GCA) clinical variations correlate with specific inflammatory cytokine messenger RNA (mRNA) patterns in temporal arteries. These distinct inflammatory profiles in GCA may guide tailored treatment strategies.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Giant Cell Arteritis (GCA) is a large-vessel vasculitis characterized by significant clinical heterogeneity.
- Understanding the molecular basis of GCA's varied presentations is crucial for targeted therapies.
- Tissue-specific inflammatory responses, particularly cytokine profiles, are implicated in disease pathogenesis.
Purpose of the Study:
- To investigate the correlation between clinical heterogeneity in Giant Cell Arteritis (GCA) and distinct tissue-specific inflammatory response patterns.
- To identify specific cytokine messenger RNA (mRNA) profiles associated with different clinical manifestations of GCA.
Main Methods:
- Analysis of temporal artery biopsy specimens from 23 GCA patients.
- Semiquantification of cytokine mRNA transcripts (IL-2, IFN-gamma, IL-1 beta, IL-10, IL-12) using reverse transcriptase-polymerase chain reaction and oligonucleotide hybridization.
- Correlation of cytokine mRNA expression patterns with clinical features: jaw claudication, visual abnormalities, fever, polymyalgia rheumatica (PMR), and giant cell formation.
Main Results:
- All temporal artery tissues expressed inflammatory cytokines.
- Interleukin-2 (IL-2), Interferon-gamma (IFN-gamma), and IL-1 beta mRNA distinguished inflammatory patterns correlating with clinical manifestations.
- Ischemic symptoms (jaw claudication/visual) associated with higher IFN-gamma and IL-1 beta mRNA; fever with lower IFN-gamma; giant cell formation with IFN-gamma; PMR with higher IL-2 mRNA.
Conclusions:
- Clinical heterogeneity in GCA is directly correlated with specific cytokine mRNA expression profiles in affected temporal arteries.
- Distinct T-cell effector functions underlie GCA disease patterns, differentiating between local ischemic, systemic, or PMR-associated involvement.
- Defining these inflammatory patterns in GCA offers a pathway for developing differentiated therapeutic strategies.